Zujun Li
NYU Langone Health(US)New York University(US)
Publications by Year
Research Areas
Head and Neck Cancer Studies, Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research, Radiopharmaceutical Chemistry and Applications, Lung Cancer Treatments and Mutations
Most-Cited Works
- → Human papillomavirus and survival of patients with sinonasal squamous cell carcinoma(2019)73 cited
- → Trimodality Management of Sinonasal Undifferentiated Carcinoma and Review of the Literature(2012)65 cited
- → Recent advances of novel targeted therapy in non-small cell lung cancer(2009)65 cited
- → Phase II, Randomized Study of Spartalizumab (PDR001), an Anti–PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer(2021)57 cited
- → Structure−Activity Relationship of 3-Substituted N-(Pyridinylacetyl)-4- (8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)- piperidine Inhibitors of Farnesyl-Protein Transferase: Design and Synthesis of in Vivo Active Antitumor Compounds(1997)52 cited
- → Socioeconomic and Racial Disparities and Survival of Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma(2020)48 cited
- Initial experience with oropharynx-targeted radiation therapy for metastatic squamous cell carcinoma of unknown primary of the head and neck.(2014)
- → Patterns of Medical Cannabis Use among Cancer Patients from a Medical Cannabis Dispensary in New York State(2019)35 cited
- → Inhibitors of Farnesyl Protein Transferase. 4-Amido, 4-Carbamoyl, and 4-Carboxamido Derivatives of 1-(8-Chloro-6,11-dihydro-5H-benzo[5,6]- cyclohepta[1,2-b]pyridin-11-yl)piperazine and 1-(3-Bromo-8-chloro-6,11- dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl)piperazine(1998)28 cited
- → Primary Surgical Treatment in Very Advanced (T4b) Oral Cavity Squamous Cell Carcinomas(2021)26 cited